Rchr
J-GLOBAL ID：201701004244916984
Update date: Oct. 09, 2024
Imamura Yoshinori
イマムラ ヨシノリ | Imamura Yoshinori
Affiliation and department：
Job title：
Assistant Professor
Research field (3)：
Hematology and oncology
, Tumor diagnostics and therapeutics
, Tumor biology
Papers (71)：
-
Yoshiaki Nagatani, Naomi Kiyota, Yoshinori Imamura, Taiji Koyama, Yohei Funakoshi, Masato Komatsu, Tomoo Itoh, Masanori Teshima, Ken-Ichi Nibu, Kazuko Sakai, et al. Different characteristics of the tumor immune microenvironment among subtypes of salivary gland cancer. Asia-Pacific journal of clinical oncology. 2024
-
Yoshinori Imamura, Naomi Kiyota, Makoto Tahara, Takeshi Kodaira, Ryuichi Hayashi, Hiroshi Nishino, Yukinori Asada, Hiroki Mitani, Shigemichi Iwae, Naoki Nishio, et al. Effect of acute kidney injury and overall survival in patients with postoperative head and neck cancer who received chemoradiotherapy with cisplatin: A supplementary analysis of the phase II/III trial of JCOG1008. Cancer medicine. 2024. 13. 18. e70235
-
T. Koyama, N. Kiyota, S. Boku, Y. Imamura, N. Shibata, H. Satake, K. Tanaka, H. Hayashi, T. Onoe, Y. Asada, et al. Corrigendum to ‘A phase II trial of paclitaxel plus biweekly cetuximab for patients with recurrent or metastatic head and neck cancer previously treated with both platinum-based chemotherapy and anti-PD-1 antibody’: [ESMO Open volume 9 issue 6 (2024) 103476] (ESMO Open (2024) 9(6), (S2059702924012456), (10.1016/j.esmoop.2024.103476)). ESMO Open. 2024. 9. 8
-
T. Koyama, N. Kiyota, S. Boku, Y. Imamura, N. Shibata, H. Satake, K. Tanaka, H. Hayashi, T. Onoe, Y. Asada, et al. A phase II trial of paclitaxel plus biweekly cetuximab for patients with recurrent or metastatic head and neck cancer previously treated with both platinum-based chemotherapy and anti-PD-1 antibody. ESMO Open. 2024. 9. 6
-
今村 善宣, 能勢 拓, 大幡 真也, 乙井 一典, 森 健太, 辻 高寛, 宮田 吉晴, 金原 史朗, 長谷 善明, 小山 泰司, et al. 進行・再発・転移の固形腫瘍における血栓塞栓症と出血リスク PROVE-emboli試験post-hoc解析. 日本血栓止血学会誌. 2024. 35. 2. 336-336
ｍore...
MISC (90)：
-
今村善宣, 能勢拓, 大幡真也, 乙井一典, 乙井一典, 森健太, 辻高寛, 宮田吉晴, 金原史朗, 長谷善明, et al. 進行・再発・転移の固形腫瘍における血栓塞栓症と出血リスク:PROVE-emboli試験post-hoc解析. 日本血栓止血学会誌. 2024. 35. 2
-
今村善宣, 能勢拓, 宮田吉晴, 小山泰司, 長谷善明, 金原史朗, 船越洋平, 清田尚臣, 藥師神公和, 南博信. がん関連静脈血栓塞栓症に対するアピキサバン療法の出血リスク予測:多施設共同第2相臨床試験副次的解析. 日本内科学会雑誌. 2023. 112
-
今村善宣, 能勢拓, 大幡真也, 森健太, 乙井一典, 宮田吉晴, 金原史朗, 長谷善明, 小山泰司, 船越洋平, et al. 進行・再発・転移の未治療固形がん患者における静脈血栓塞栓症の前向き観察研究の統合解析. 日本血栓止血学会誌. 2023. 34. 2
-
能勢拓, 今村善宣, 大幡真也, 森健太, 乙井一典, 小山泰司, 長谷義明, 金原史朗, 船越洋平, 清田尚臣, et al. がん治療前の悪性腫瘍関連下肢静脈血栓塞栓症のリスク因子に関する検討:PROVE-emboli study. 日本腫瘍循環器学会学術集会抄録集(Web). 2023. 6th
-
瓜生開人, 出水祐介, 窪田光, 美馬正幸, 福光延吉, 今村善宣, 明石昌也, 副島俊典. 頭頸部粘膜悪性黒色腫に対する陽子線治療+adjuvant Nivolumab療法. 頭頸部癌. 2023. 49. 2
ｍore...
Books (3)：
-
頭頸部がん診療ガイダンス第2版 / 頭頸部がん診療ガイダンス第2版
金原出版 2018
-
頭頸部がん診療ガイドライン第2版 / 頭頸部がん診療ガイドライン第2版
金原出版 2018
-
頭頸部がん薬物療法ハンドブック第2版 / 頭頸部がん薬物療法ハンドブック第2版
中外医学社 2017
Lectures and oral presentations (24)：
-
Relationship between tumor burden to growth rate and treatment outcomes of nivolumab for patients with head and neck squamous carcinoma.
(ASCO-SITC 2019)
-
肺動脈原発内膜肉腫の3例
(第1回日本腫瘍循環器学会学術集会 2018)
-
悪性腫瘍関連静脈血栓寒栓症に対する包括的研究:J-CAV project in progress
(第1回日本腫瘍循環器学会学術集会 2018)
-
Nutritional Support Dependence after Curative Chemoradiotherapy in Head and Neck Cancer: a Supplementary Analysis of a Phase II Trial (JCOG0706S1)
(ESMO2018 2018)
-
A Phase II Trial of Docetaxel plus Cisplatin in Recurrent and/or Metastatic Non-squamous Cell Carcinoma of Head and Neck
(ESMO2018 2018)
ｍore...
Education (1)：
- - 2015 Kobe University Graduate School of Medicine
Professional career (1)：
Awards (3)：
- 2018/07 - Japan Society of Clinical Oncology Young Investigator Award Docetaxel plus Cisplatin in Recurrent and/or Metastatic Non-squamous Cell Carcinoma of Head and Neck: a Phase II Trial.
- 2015/03 - The 3rd International Symposium of Training Plan for Oncology Professionals Harvard University Merit Award Comparison of 2D- and 3D-culture models as drug-testing platforms in breast cancer
- 2013/03 - 神戸大学医学部附属病院 Best lecture award 研修医ミーティング
Return to Previous Page
